Peptide Research
MOTS-C Shelf Life: 21-Day Stability Study Challenges Common Degradation Claims
The Internet Says MOTS-C Goes Bad Fast. Our 21-Day Laboratory Study Tells a Different Story. Few peptides generate more debate
Janoshik Weighs In on Eloralintide: What the Data Actually Shows and Why Researchers Are Paying Attention
Over the past several months, few compounds have generated as much excitement—and as much debate—as Eloralintide. Between growing interest in
Bioglutide Scam? Researchers Raise Major Questions About NA-931 Claims
The Bioglutide Controversy: Why Researchers Are Asking Serious Questions About NA-931 The weight-loss research world has become the pharmaceutical equivalent
How Bimagrumab and Semaglutide May Revolutionize Fat Loss While Preserving Lean Mass
The world of metabolic research is evolving fast. For years, the conversation around weight management focused almost entirely on one
Why Big Pharma Is Suddenly Obsessed With Amylin Agonists
The Next Massive Wave in Metabolic Research After GLP-1? For years, GLP-1-focused compounds dominated nearly every conversation surrounding metabolic and obesity-related
Ribupatide: The Next Major Oral GLP-1/GIP Weight Loss Drug?
The obesity treatment market is evolving rapidly, with pharmaceutical companies racing to develop more effective and convenient weight management therapies.